Alta Charo has been appointed to the panel that will provide on-going oversight for the million-person research cohort being recruited for President Obama's Precision Medicine Initiative, which aims to individualize and improve healthcare through genetics and other new technologies.

Submitted by Law School News on November 30, 2015

This article appears in the categories: Activities & Scholarship